EFLUELDA TIV 0.5 mL susp inj 60 µg 1 pce

7680698630050 CH-69863 J07BB02 08.08.

No images available

Details

Product number
6986303
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
haemagglutininum influenzae A (H1N1) (Virus souche A/Missouri/11/2025 (H1N1)-like: reassortant virus IVR-278 derived from A/Switzerland/6849/2025) 60 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/1454/2025 (H3N2)-like: reassortant virus SAN-049A derived from A/Michigan/105/2025) 60 µg, haemagglutininum influenzae B (Virus souche B/Tokyo/EIS13-175/2025-like: derived from B/Tokyo/EIS-175/2025 (Victoria lineage), wild type) 60 µg, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas anhydricus, octoxinolum-9, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.96 mg.

Articles (1)

Efluelda TIV 0.5 mL, suspension injectable en seringue pré-remplie
suspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
27/05/2026
Professional SmPC
Français
27/05/2026
Professional SmPC
Italien
27/05/2026

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
60.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
60.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
60.0 UG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
dinatrii phosphas
- Substance HNIDK
natrii dihydrogenophosphas anhydricus
- Substance HNIDK
octoxinolum-9
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.96 MG Substance HBESI

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
69863
Drug name
Efluelda TIV, suspension injectable en seringue pré-remplie
Galenic form
SUPAS
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
07/04/2025
Authorization expiration date
06/04/2030
IT number
08.08.
Domain
Human medicine

Packaging details

Description (FR)
EFLUELDA TIV 0.5 mL susp inj 60 µg 1 pce
Description (DE)
EFLUELDA TIV 0.5 mL Inj Susp 60 µg 1 Stk
Market launch
09/04/2026
Narcotic (BTM)
No

Other packaging sizes

EFLUELDA TIV 0.5 mL susp inj 60 µg 1 pce
1 FESP
View
Buy us a coffee Explore the data